Retinal Nrf2 expression in normal and early streptozotocin-diabetic rats

Area of Science:

• Ophthalmology
• Diabetology
• Molecular Biology

Background:

• Diabetic retinopathy is a major cause of vision loss in diabetes patients.
• Hyperglycemia is linked to retinal oxidative stress, but the exact mechanism remains unclear.
• Nuclear factor erythroid 2-related factor 2 (Nrf2) is crucial for cellular defense against oxidative damage.

Purpose of the Study:

• To investigate the role of Nrf2 and Keap1 in the retina during early diabetes.
• To determine if oxidative stress occurs in the retina shortly after diabetes induction.

Main Methods:

• Diabetes was induced in adult Long Evans rats using streptozotocin.
• Retinal expression of Nrf2 and Keap1 was analyzed at 7, 20, and 45 days post-injection.
• Analysis included mRNA, protein levels, and Keap1-Nrf2 complex integrity.

Main Results:

• A transient decrease in Nrf2 mRNA and protein was observed at 7 and 20 days, followed by recovery and an increase at 45 days.
• Keap1 immunoprecipitation showed no dissociation of the Keap1-Nrf2 complex in diabetic retinas.
• Glutathione levels and superoxide dismutase activity remained unchanged, indicating no significant oxidative stress.

Conclusions:

• Early diabetes induction in rats does not appear to cause significant oxidative stress in the retina.
• The Nrf2 pathway remains largely intact, with transient changes in Nrf2 expression that recover over time.